🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II study to determine the safety and efficacy of tislelizum...
Status
Unknown
Location
Tianjin Medical University Second Hospital
Start Date
2021-12-27
Trial ID
NCT05418309
Treatments Being Tested
The purpose of this study is to find out if there is a benefit of adding He...
Status
Completed
Location
Hays Medical Center
Start Date
2009-07
Trial ID
NCT00944047
Treatments Being Tested
This phase II trial studies how well onvansertib in combination with gemcit...
Status
Withdrawn
Location
OHSU Knight Cancer Institute
Start Date
2024-08-01
Trial ID
NCT06398587
This is an investigator-initiated industry-supported phase 1 clinical trial...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-11-12
Trial ID
NCT05075993
This study aims to optimize neoadjuvant therapy for HER2-positive breast ca...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT06973525
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as paclitaxel, work in differen...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2006-02
Trial ID
NCT00313599
Treatments Being Tested
This study will look at the efficacy and safety of QL1706 plus albumin-boun...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-06
Trial ID
NCT06404463
This study is looking to see whether the combination of Tucidinostat and na...
Status
Unknown
Location
Hunan Cancer Hospital
Start Date
2023-02-07
Trial ID
NCT05633914
Treatments Being Tested
The study is a first-in-human (FIH), open-label, multi-center phase 1/2 stu...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-04-29
Trial ID
NCT06385925
One-arm, multi-center clinical trial of paclitaxel (albumin-binding) combin...
Status
Unknown
Location
Multiple Locations
Start Date
2019-11
Trial ID
NCT04148885
Treatments Being Tested